Get the latest data on Patient Zero and the Blue Green Algae Pilot Study 

A pilot study that aims to see if bone marrow stem cells stimulated by a natural substance with the trade name Blue Green Algae, might have a beneficial effect on the status of HIV+ patients.

Read More And View Latest Patient Results

July 2010

The Peter Schick Foundation would like to warmly thank all its donors for the month. Your generous donations continue to help further our research and future clinical trials.

Spirulina Stops HIV! 

Spirulina is gaining more attention from medical scientists as a nutraceutical and source of potential pharmaceuticals. There are several new peer reviewed scientific studies about Spirulina's ability to inhibit viral replication, strengthen both the cellular and humoral arms of the immune system and cause regression and inhibition of cancers.

ESPN and The Peter Schick Foundation
LaFern Cusack and Peter Schick sit down and talk about the history of the foundation and what is being done today. The radio interviews can be listened to below:

http://espnsocalexperience.blogspot.com

Promising AIDS Treatment News

New data indicating enhanced survival with combination antiretroviral therapies may be some of the best news to come along in along time, report AIDS researchers.

The long-awaited results of the ACTG (AIDS Clinical Trials Group) 175 study were announced to a large standing room only crowd at the at the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. The ACTG 175 study was a randomized, double-blind, placebo controlled trial involving 2,467 HIV positive patients randomized to one of four treatment groups.

Read More

Submit your email below to receive timely information on the latest research and protocols taking place around the globe as well as collaborative research being done at Schick Research.